Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors

Inclusion Criteria:

• Active arthritis at screening/baseline as indicated by >/= 3 tender/painful and 3swollen joints

• Active plaque psoriasis at screening

• Inadequate efficacy or lack of toleration to previously administered TNF inhibitor

Exclusion Criteria:

• Non-plaque forms of psoriasis (with exception of nail psoriasis)

• History of autoimmune rheumatic disease other than PsA; also prior history of orcurrent, rheumatic inflammatory disease other than PsA